Suppr超能文献

商业索赔数据库中与新生儿戒断综合征相关的产妇危险因素的流行率:2011-2015 年。

Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.

机构信息

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida.

出版信息

Pharmacotherapy. 2019 Oct;39(10):1005-1011. doi: 10.1002/phar.2315. Epub 2019 Aug 22.

Abstract

BACKGROUND

Despite the rising incidence of neonatal abstinence syndrome (NAS), data evaluating trends in maternal risk factors associated with NAS have not been available for recent years, a period characterized by declining opioid prescriptions. The objective of this study was to examine the prevalence of opioid- and non-opioid-related factors associated with NAS, and by mutually exclusive subgroups of deliveries without prescription-opioid use, with prescription-opioid use, and with opioid-use disorder (OUD).

METHODS

A cohort of pregnancies resulting in live births in a commercial claims data base in 2011-2015 was identified. Examples of maternal risk factors of interest included antepartum prescription-drug use (e.g., opioids, selective serotonin reuptake inhibitors [SSRIs], antipsychotics) and nonprescription-related factors (e.g., smoking, OUD).

RESULTS

A total of 659 cases of NAS among 621,940 deliveries was identified. Among NAS deliveries, prescription opioids were the most commonly used drug-class (39.0%). Adjusted relative risk (RR) for NAS was 5.43 (95% confidence interval [CI] 4.25-6.95), followed by SSRIs (20.9%; RR 3.16, CI 2.43-4.11); OUD was noted in 36.3% of the deliveries (RR 40.74, CI 22.64-73.32). In the subgroup of deliveries without a prescription opioid (33% of overall NAS deliveries), the absolute incidence of NAS was low (0.3 cases/1000 deliveries), and SSRIs were the most commonly used medication class (32.7%; RR 10.21, CI 7.28-14.31). In the subgroup of deliveries with an opioid prescription, the absolute incidence of NAS was 7.7/1000 (29% of all overall NAS deliveries), and 22.7% of these deliveries were exposed to one other psychotropic agent in addition to the opioid, most commonly an SSRI (18.0%). In the subgroup of deliveries with a diagnosis of OUD, the NAS incidence was high (214.3/1000 [36% of all NAS cases]).

CONCLUSION

A third of NAS deliveries did not have evidence of prescription opioids. Other psychotropic medications, especially SSRIs, were strong predictors of NAS in this stratum but had no relevance among deliveries with OUD, suggesting varying etiologies and the need for tailored preventive approaches to reduce NAS effectively.

摘要

背景

尽管新生儿戒断综合征(NAS)的发病率不断上升,但近年来,评估与 NAS 相关的产妇风险因素趋势的数据尚不可用,这一时期的特点是阿片类药物处方数量下降。本研究的目的是检查与 NAS 相关的阿片类药物和非阿片类药物相关因素的流行情况,并按无处方阿片类药物使用、有处方阿片类药物使用和阿片类药物使用障碍(OUD)的相互排斥亚组进行检查。

方法

在 2011-2015 年的商业索赔数据库中确定了一项与活产相关的妊娠队列。感兴趣的产妇风险因素包括产前处方药使用(例如阿片类药物、选择性 5-羟色胺再摄取抑制剂 [SSRIs]、抗精神病药)和非处方相关因素(例如吸烟、OUD)。

结果

在 621940 例分娩中,共发现 659 例 NAS。在 NAS 分娩中,处方类阿片类药物是最常用的药物类别(39.0%)。NAS 的调整后相对风险(RR)为 5.43(95%置信区间 [CI] 4.25-6.95),其次是 SSRIs(20.9%;RR 3.16,CI 2.43-4.11);OUD 在 36.3%的分娩中(RR 40.74,CI 22.64-73.32)。在没有处方阿片类药物的分娩亚组(总体 NAS 分娩的 33%)中,NAS 的绝对发生率较低(每 1000 例分娩 0.3 例),SSRIs 是最常用的药物类别(32.7%;RR 10.21,CI 7.28-14.31)。在有阿片类药物处方的分娩亚组中,NAS 的绝对发生率为每 1000 例 7.7 例(占所有总体 NAS 分娩的 29%),其中 22.7%的分娩除了阿片类药物外还接触到另一种精神药物,最常见的是 SSRIs(18.0%)。在 OUD 诊断的分娩亚组中,NAS 的发生率较高(每 1000 例 214.3 例[占所有 NAS 病例的 36%])。

结论

三分之一的 NAS 分娩没有处方阿片类药物的证据。其他精神药物,尤其是 SSRIs,是该亚组中 NAS 的强预测因素,但在 OUD 分娩中没有相关性,表明存在不同的病因,并需要采取有针对性的预防措施来有效减少 NAS。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验